Real-time, personalized medicine through wearable sensors and dynamic predictive modeling: A new paradigm for clinical medicine

Current Opinion in Systems Biology - Tập 20 - Trang 17-25 - 2020
Jonathan Tyler1,2, Sung Won Choi1, Muneesh Tewari3
1Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA
2Department of Mathematics, University of Michigan, Ann Arbor, MI, USA
3Division of HematolOgy and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI USA

Tài liệu tham khảo

Harrap, 2002, Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2, Arterioscler Thromb Vasc Biol., 22, 874, 10.1161/01.ATV.0000016258.40568.F1 Ozaki, 2002, Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction, Nat Genet, 32, 650, 10.1038/ng1047 Yamada, 2002, Prediction of the risk of myocardial infarction from polymorphisms in candidate genes, N Engl J Med, 347, 1916, 10.1056/NEJMoa021445 Bown, 2004, Cytokines, their genetic polymorphisms, and outcome after abdominal aortic aneurysm repair, Eur J Vasc Endovasc Surg, 28, 274, 10.1016/j.ejvs.2004.05.008 Hakonarson, 2005, Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial, J Am Med Assoc, 293, 2245, 10.1001/jama.293.18.2245 Cohen, 2006, Sequence variations in PCSK9, low LDL, and protection against coronary heart disease, N Engl J Med, 354, 1264, 10.1056/NEJMoa054013 Liu, 2012, Identifying critical transitions and their leading biomolecular networks in complex diseases, Sci Rep, 2, 813, 10.1038/srep00813 Chen, 2012, Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers, Sci Rep, 2, 342, 10.1038/srep00342 Ziegler, 2012, Personalized medicine using DNA biomarkers: a review, Hum Genet, 131, 1627, 10.1007/s00439-012-1188-9 Liu, 2014, Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers, Med Res Rev, 34, 455, 10.1002/med.21293 Looker, 2015, SUMMIT Investigators, Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes, Diabetologia, 58, 1363, 10.1007/s00125-015-3535-6 Soe, 2018, Identifying protein biomarkers in predicting disease severity of dengue virus infection using immune-related protein microarray, Medicine, 97, 10.1097/MD.0000000000009713 Yao, 2018, Identification of blood biomarkers for alzheimer's disease through computational prediction and experimental validation, Front Neurol, 9, 1158, 10.3389/fneur.2018.01158 Liu, 2019, Detection for disease tipping points by landscape dynamic network biomarkers, Natl Sci Rev, 6, 775, 10.1093/nsr/nwy162 Liu, 2019, Identifying critical state of complex diseases by single-sample-based hidden Markov model, Front Genet, 10, 285, 10.3389/fgene.2019.00285 Younes, 2019, Identifying changepoints in biomarkers during the preclinical phase of alzheimer's disease, Front Aging Neurosci, 11, 74, 10.3389/fnagi.2019.00074 Ong, 2020, Usefulness of certain protein biomarkers for prediction of coronary heart disease, Am J Cardiol, 125, 542, 10.1016/j.amjcard.2019.11.016 Sun, 2020, Identifying critical states of hepatocellular carcinoma based on landscape dynamic network biomarkers, Comput Biol Chem, 85, 107202, 10.1016/j.compbiolchem.2020.107202 Wilson, 2009, Systematic review: family history in risk assessment for common diseases, Ann Intern Med, 151, 878, 10.7326/0000605-200912150-00177 Brentnall, 2018, Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density, JAMA Oncol, 4, 10.1001/jamaoncol.2018.0174 Li, 2019, Using machine learning and the electronic health record to predict complicated Clostridium difficile infection, Open Forum Infect Dis, 6, ofz186, 10.1093/ofid/ofz186 Mars, 2020, Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers, Nat Med, 26, 549, 10.1038/s41591-020-0800-0 Yang, 2010, A review of accelerometry-based wearable motion detectors for physical activity monitoring, Sensors, 10, 7772, 10.3390/s100807772 Rhee, 2015, Evaluating the validity of an automated device for asthma monitoring for adolescents: correlational design, J Med Internet Res, 17, e234, 10.2196/jmir.4975 Li, 2017, Digital health: tracking physiomes and activity using wearable biosensors reveals useful health-related information, PLoS Biol, 15, 10.1371/journal.pbio.2001402 Ohri, 2017, Continuous activity monitoring during concurrent chemoradiotherapy, Int J Radiat Oncol Biol Phys, 97, 1061, 10.1016/j.ijrobp.2016.12.030 Guk, 2019, Evolution of wearable devices with real-time disease monitoring for personalized healthcare, Nanomaterials (Basel), 9, 10.3390/nano9060813 He, 2019, Computational analysis of continuous body temperature provides early discrimination of graft-versus-host disease in mice, Blood Adv, 3, 3977, 10.1182/bloodadvances.2019000613 Pavic, 2019, Mobile health technologies for continuous monitoring of cancer patients in palliative care aiming to predict health status deterioration: a feasibility study, J Palliat Med Schüssler-Fiorenza Rose, 2019, A longitudinal big data approach for precision health, Nat Med, 25, 792, 10.1038/s41591-019-0414-6 Zahiri, 2019, Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - toward an early diagnosis of CIPN, J. Geriatr. Oncol., 10, 960, 10.1016/j.jgo.2019.01.010 Radin, 2020, Harnessing wearable device data to improve state-level real-time surveillance of influenza-like illness in the USA: a population-based study, The Lancet Digital Health, 2, e85, 10.1016/S2589-7500(19)30222-5 Knowler, 2002, Diabetes Prevention Program Research Group, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512 Tabák, 2012, Prediabetes: a high-risk state for diabetes development, Lancet, 379, 2279, 10.1016/S0140-6736(12)60283-9 Guzick, 1978, Efficacy of screening for cervical cancer: a review, Am. J. Public Health., 68, 125, 10.2105/AJPH.68.2.125 Strogatz, 2018 Scheffer, 2009, Early-warning signals for critical transitions, Nature, 461, 53, 10.1038/nature08227 Cox, 2018, Use of wearable, mobile, and sensor technology in cancer clinical trials, JCO Clin Cancer Inform, 2, 1, 10.1200/CCI.17.00147 Piwek, 2016, The rise of consumer health wearables: promises and barriers, PLoS Med, 13, 10.1371/journal.pmed.1001953 Fisch, 2016, Using technology to improve cancer care: social media, wearables, and electronic health records, Am Soc Clin Oncol Educ Book, 35, 200, 10.1200/EDBK_156682 Tabbara, 2002, Allogeneic hematopoietic stem cell transplantation: complications and results, Arch Intern Med, 162, 1558, 10.1001/archinte.162.14.1558 Gyurkocza, 2010, Allogeneic hematopoietic cell transplantation: the state of the art, Expert Rev. Hematol., 3, 285, 10.1586/ehm.10.21 Ferrara, 1991, Graft-versus-host disease, N Engl J Med, 324, 667, 10.1056/NEJM199103073241005 He, 2018, Biomarkers in graft-versus-host disease: from prediction and diagnosis to insights into complex graft/host interactions, Curr. Hematol. Malig. Rep., 13, 44, 10.1007/s11899-018-0433-2 Zhao, 2019, Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading?, Biomark Res, 7, 17, 10.1186/s40364-019-0167-x Sprinthall, 1990 Liu, 2016, Personalized characterization of diseases using sample-specific networks, Nucleic Acids Res, 44, e164, 10.1093/nar/gkw772